Disseminated Intravascular Coagulation in Cattle with Abomasal Displacement
|
|
- Caitlin Grant
- 5 years ago
- Views:
Transcription
1 Disseminated Intravascular Coagulation in Cattle with Abomasal Displacement Kemal IRMAK ), Kürşat TURGUT ) ) Department of Internal Medicine, Faculty of Veterinary Medicine, University of Selcuk, 4203, Campus, Konya-TURKEY. *: Contact address: Department of Internal Medicine, Faculty of Veterinary Medicine, University of Selcuk, 4203, Campus, Konya-TURKEY. kirmak@selcuk.edu.tr, Tel /274, Fax: ABSTRACT The purpose of the study was to evaluate the haemostatic function in cattle with abomasal displacement (AD) and to reflect the occurrence of disseminated intravascular coagulation (DIC). Ten adult cattle with left displacement of abomasum (LDA) (Group I), ten adult cattle with right displacement of abomasum with volvulus (RDA) (Group II) and ten clinically healthy adult cattle (Control Group) were used as material. Numbers of platelets (PLT) and coagulation tests (activated partial thromboplastin time (APTT), prothrombin time (PT), thrombin time (TT), serum fibrin/fibrinogen degradation products (FDPs), fibrinogen) were measured before the surgical treatment of cattle with LDA and RDA. Activated partial thromboplastin time was only prolonged in group II compared with the control and group I (p<0.05). However, when the individual values of coagulation profiles of each cow were evaluated, 2 cattle in group I and 3 cattle in group II had at least 3 abnormal coagulation profiles, which reflect the occurrence of DIC. These cattle died after surgical treatment. These 2 cattle with LDA had abnormal APTT, FDPs and PLT values. 3 cattle with RDA had abnormal APTT, PT, TT, FDPs and PLT values. The three most common positive tests on coagulation profile of group I and II were found to be APTT (5 cases), FDPs (5 cases), thrombocytopenia (5 cases). Results of the study indicated that cattle with AD had a spectrum of hemostatic dysfunction and DIC was a significant risk factor for mortality. Key word: Coagulation profile, Cattle, Abomasal displacement. INTRODUCTION Abomasal displacement occurs most frequently in high yielding cows during early lactation (Breukink, 99; Hund and Nelson, 995; Turgut and Ok, 997). While LDA, in which the abomasum is trapped between the rumen and the left abdominal wall, is more commonly diagnosed, RDA is usually accompanied by a degree of volvulus, in which the rotation of the proximal duodenum, abomasum and omasum occur, and is therefore a more serious problem (Wallace, 989; Jean et al., 989; Constable, 99). There have been many papers describing the diagnosis and treatment of AD as well as the theory of causation, pathophysiology, and prognosis (Yamahato, 982a; Yamahato, 982b; Muylle et al., 990; Breukink, 99). However, there is no report evaluating the coagulation profiles in cattle with abomasal displacement. There is only one study in which APTT and PT have been evaluated in cows with LDA, and no difference has been found (Ogurtan et al., 2003). Disseminated Intravascular Coagulation is a continuously progressing process, it can be subdivided into three phases: phase I; compensated activation of the haemostatic system, phase II; decompensated activation of
2 the haemostatic system, phase III; full-blown DIC (Muller-Berghaus et al., 999). The pathologic process is characterized by widespread fibrin deposition in the microcirculation with subsequent ischemic damage and by the development of a hemorrhagic diathesis caused by the consumption of procoagulans and hyperactivity of fibrinolysis (Morris, 990b). In large animals DIC has been described in association with forms of localized and/or systemic septic processes (e.g., salmonellosis, metritis, mastitis), neoplasia, gastrointestinal disorders (e.g., strangulating intestinal obstruction, acute enteritis, protein-losing enteropathy), renal disease, and hemolytic anemia (Morris, 990b). Numerous laboratory tests of haemostasis may be abnormal during DIC; however, no one test consistently or specifically provides a definitive diagnosis (Morris, 990b). The minimum laboratory data needed to evaluate haemostasis in large animals are the PLT, plasma fibrinogen contents, PT (extrinsic system), APTT (intrinsic system), and FDPs. The results of these tests will also vary according to the severity and fulminant nature of the process and the time of sampling (Blood et al., 983; Morris 990a). The purpose of the study reported here was to evaluate the haemostatic function in cattle with AD and to reflect the occurrence of DIC. MATERIALS AND METHODS Animals: In this study, ten adult cattle with LDA (Group I), ten adult cattle with RDA (Group II) and ten clinically healthy adult cattle (Control Group) were used as material. All of these cows were Holstein. Ages of the animals varied from 3 to 7 years. Their mean (± sd) age was 4±.5 years. All were in early lactation (7 to 2 days) and have been fed with high concentrate diet. On admission the animals had been ill on average for 3 days. Clinical examinations: The cattle with AD showed loss of appetite, decreased rumen motility and milk production, and little or scant defecation. All animals were examined with regard to abdominal ausculopercussion, ballotment of abdomen for splashing sound, rectal examination and abdominal ultrasonography. After tentative diagnosis of AD, the diagnosis was verified by operation. Venous blood samples (K-EDTA) for haematological examination (PLT) and sodium citrate added blood samples for coagulation tests (APTT, PT, TT, FDPs, fibrinogen) were taken from the jugular vein before the surgical treatment of AD. Haematological examinations: The number of platelets were measured by automatic haemocell counter (Medonic, Ca530). Coagulation testing: 9 ml of venous blood sample for the determination of APTT, PT, TT, fibrinogen and FDPs concentrations were collected into collection tubes including ml of 3.8 % sodium citrate and centrifuged at 500 g for 5 minutes. The plasma samples were separated from blood within 30 minutes of blood collection and measurements were performed within 2-24 hours. The activated partial thromboplastin time (STA-CK Prest 5, Kit Cat. No: 00597) and PT (STA - Neoplastine Cl Plus, Kit Cat. No: 00597) were measured by STA analyser. TT (Thromboquik TM ; Product no: 3555) and fibrinogen (Fibriquik ; Product No: 35529) were measured by Thromblyser-XR (Organon Teknika). FDP were determined by Latex agglutination test methods using FDP plasma kit (Kit Cat. No: 00540; Organon Teknika Corp; Durham, NC, USA). 2
3 Statistical analysis: FDPs were compared with Kruskal-Wallis test statistic. Anova Duncan test has been used for other analyses. A value of P< 0.05 was considered statistically significant for all analyses. (SPSS for Windows; Statistical Package of Social Science, SPSS Inc. USA) RESULTS All cattle in group II had various degree of volvulus ( o ) Table shows the mean±sd APTT, PT, TT, fibrinogen and PLT values in group I, II and the control group and their statistical significance. Mean±SD and median FDPs concentrations are also given in table. Individual values of all cattle are given in table 2. Only APTT was prolonged in group II compared with the control and group I (p<0.05). However, when the individual values of coagulation profiles of each cow were evaluated, 2 cattle in group I (case 4 a and 5 a ) and 3 cattle in group II (case 3 b, 6 b and 9 b ) had at least 3 abnormal coagulation profiles (APTT >54.0 sec, PT 30.9 sec, TT >3.6 sec, FDPs >5 µg/ml, PLT 50x03/mm3), which reflect the occurrence of DIC (Table 2). These cattle (case 4 a and 5 a in group I; case 3 b, 6 b and 9 b in group II) died after surgical treatment (Table 2). Case 4 b and 5 a (cattle with LDA) had abnormal APTT, FDPs and PLT values. Case 3 b, 6 b and 9 b (cattle with RDA) had abnormal APTT, PT, TT, FDPs and PLT values (Table 2). One cow in group II (case b ) with normal coagulation profile results also died after surgical treatment. The highest and lowest values for the control group of cattle were APTT 50.0 sec, PT 26.9 sec, TT 3.6 sec, FDPs <5 µg/ml, PLT 68x03/mm 3 (Table 2). DISCUSSION Left displacement of abomasum (LDA) is a common condition of dairy cattle in which the abomasum is trapped between the rumen and the left abdominal wall rather than being in its normal position to the right of the ventral midline (Jean et al., 989). Right displacement of the abomasum (RDA) is usually accompanied by a degree of volvulus, in which the rotation of the proximal duodenum, abomasum and omasum occur. Thus, RDA with volvulus is a more serious problem (Wallace, 989; Constable, 99). In this study, all cattle with RDA (group II) had various degree of volvulus ( o ). And, 2 cattle with LDA and 3 cattle with RDA and volvulus died despite surgical treatment. Table. The mean±sd activated partial thromboplastin time (APTT), prothrombin time (PT), thrombin time (TT), fibrinogen and numbers of platelet (PLT) values, mean±sd and median serum fibrin/fibrinogen degradation products (FDPs) concentrations in group I (LDA), II (RDA) and the control group and their statistical significance. PARAMETERS Control Group (n:0) Mean±SD LDA (n:0) Mean±SD RDA (n:0 Mean±SD APTT (sec) 36.49±8.43a 45.63±26.24ab 63.38±30.58b * PT (sec) 24.0± ± ±8.04 TT (sec) 25.30± ± ±4.99 Fibrinogen (mg/dl) ± ± ±69.38 FDPs (μg/ml) Mean±SD Median ± ± ±0.5 PLT (0 3 /mm 3 ) 26.20± ± ±92.78 *: P<0.05 FDPs graded = <5 (µg/ml), 2= 5-20 (µg/ml), 3= >20 (µg/ml) 3
4 Table 2. Individual values of activated partial thromboplastin time (APTT), prothrombin time (PT), thrombin time (TT), serum fibrin/fibrinogen degradation products (FDPs), fibrinogen and numbers of platelet (PLT) in group I a (LDA), II b (RDA) and the control c group of cattle. Case No APTT (sec) PT (sec) TT (sec) FDPs (μg/ml) Fibrinogen (mg/dl) PLT (0 3 /mm 3 ) a < a a < a* a* a < a < a < a < a < b* < b < b* b < b < b* b < b < b* b < c < c < c < c < c < c < c < c < c < c < *: Death cows after surgical treatment The laboratory diagnosis of DIC is usually based on the prolonged APTT, PT, thrombocytopenia, hypofibrinogenemia, finding FDPs, schistocytes in blood smears, and decreased concentrations of coagulation factors (usually factors V, VIII) and antithrombin III add additional weight to the diagnosis. TT is also prolonged. Excessive coagulation is reflected by reduced plasma concentrations of platelets, coagulant and anticoagulant proteins, and increased concentrations of coagulant by-products. Fibrinolysis is indicated by elevated FDPs or reduced concentrations of fibrinolytic and antifibrinolytic proteins. No single laboratory test is, however, pathognomic for the disease (Jain, 993; Morris, 990b). A diagnosis of DIC is assumed, when at least three of five tests included in a coagulation profile are abnormal (Ritt et al., 997). In our study, the most common three tests of coagulation profiles found to be altered were APTT (2 cases), FDPs (2 cases), thrombocytopenia (2 cases) in the group I (case 4 a, 5 a ) and APTT (3 cases), FDPs (3 cases), thrombocytopenia (3 cases) in the group II (case 3 b, 6 b, 9 b ) (Table 2). 4
5 Activated partial thromboplastin time test is used to evaluate the intrinsic and common pathways. The most common cause of prolonged APTT is increased consumption of clotting factors during DIC. Liver failure and vitamin K deficiency prolong APTT, since factors II, VII, IX, and X are tested. A disseminated coagulopathy should be manifested by several abnormalities in the coagulation profile, although variable use, synthetic rates, and the half-lives of clotting factors may result in abnormality of only one clotting time (APTT or PT) (Morris, 990a). In this study, prolonged APTT was found to be common coagulation profile abnormality in cattle with LDA and RDA. Increased serum concentration of FDPs reflects the proteolytic action of plasmin on fibrin and/or fibrinogen at a rate that exceeds the clearance capacity of the mononuclear phagocyte system. Measurable serum FDPs generally indicate increased fibrinolysis response to excessive activation of coagulation (i.e., DIC); however, severe inflammatory processes, hemorrhagic disorders, or postoperative states that cause extensive intravascular fibrin deposition may elevate serum FDPs significantly. Primary (spontaneous) hyperfibrinolysis occur in people in association with chronic liver disease, neoplasia, or cardiopulmonary bypass; however, this cause for elevated serum FDPs has not been described in large animals (Morris, 990a). Finding of FDPs in 2 cattle with LDA (case 4 a, 5 a ) and 3 cattle with RDA (case 3 b, 6 b, 9 b ) in this study could be the result of DIC. Two cattle with LDA (case 4 a, 5 a ) and 3 cattle with RDA (case 3 b, 6 b, 9 b ) had thrombocytopenia (a platelet count less than 50,000/μl) in this study. Excessive consumption of platelets to fulfil their normal role in hemostasis occurs during DIC. The platelet count is a useful test for monitoring the rate and severity of consumption or destruction. Other components of the hemostatic system should be evaluated (e.g., PT, APTT, FDPs), since thrombocytopenia may be only part of a disseminated coagulopathy (Morris, 990a). Thrombocytopenia together with prolonged APTT and FDPs may show that DIC might develop in these cattle. Prothrombin time is a measure of the extrinsic and common pathways of coagulation. The most common cause of prolonged PT is increased consumption of clotting factors during DIC. Thrombin time is a measure of the rate of fibrinogen to fibrin conversion. It is prolonged when fibrinogen is less than 60 mg/dl, fibrinogen is nonfunctional, or FDPs are present that interfere with fibrin polymerization. Since hypofibrinogenemia is rare in large animals, a prolonged thrombin time most likely would indicate the presence of FDPs (Morris, 990a). Prolonged PT (case 6 b ) and prolonged TT (case 9 b ) together with prolonged APTT, FDPs and thrombocytopenia support the development of DIC in these cases. Hypofibrinogemia may result from impaired hepatic synthesis, increased consumption during DIC, degradation during primary hyperfibrinolysis, or uncompensated loss during massive hemorrhage. In spite of these mechanisms, reduced plasma fibrinogen is rare under any circumstances in large animals (Morris 990a). Hypofibrinogenemia is an uncommon manifestation of DIC in large animals and, when present, should strongly suggest concomitant liver dysfunction (Morris, 990b). Hypofibrinogenemia was not found in cattle with AD in this study. This could be the result of exclusive production of fibrinogen by liver and as an acute-phase reactant, being rapidly released in response to a variety of inflammatory and procoagulant stimuli. DIC is a recognized syndrome of abnormal hemostatic function. Most cases can be traced to platelet activation and/or the release of thromboplastins into the circulation from tissue damage in various conditions. Tissue necrosis and inflammation are common inciting causes of DIC through the release of procoagulant or of thromboplastin-like substances and the initiation of the coagulation sequence. Stagnant blood flow, acidosis, and hypoxia favor endothelial damage and DIC (Turgut, 2000). Development overstretching of abomasal wall, 5
6 thrombosis, vagus nerve damage, abomasal necrosis and peritonitis in the cases of AD, especially RDA with volvulus may cause the release of procoagulant and/or thromboplastins and incite DIC. Results of the study indicated that cattle with AD had a spectrum of hemostatic dysfunction and DIC was a significant risk factor for mortality. REFERENCES Blood, D.C., Radostits, O.M. and Henderson, J.A., 983. Veterinary Medicine, Sixth Edition, Bailliere Tindall. London., Breukink, H.J., 99. Abomasal displacement, etiology, pathogenesis, treatment and prevention. The Bovine Practitioner., 26, Constable, P.D., 99. Abomasal volvulus in cattle: Etiology and prognosis., New Orleans., proc 9 th ACVIM forum, Hund, J.C. and D. R. Nelson., 995. Right-sided abomasal displacement in dairy cattle. Vet. Med., 90, Jain, N.C., 993. Essentials of Veterinary Haematology, Lea&Febiger, Philadelphia., Jean, G.ST., Constable, PD., Hull, B.L., Rings, D.M., 989. Abomasal volvulus in cattle following correction of left displacement by casting and rolling., Cornell Vet. 79 (4), Morris, D.D., 990b. Disease of Hematopoietic and Hemolymphatic systems. In : Smith, B. P., (ed)., Large Animal Internal Medicine. The C. V. Mosby Company. Philadelphia., Morris, D.D., 990a. Alterations in the Clotting Profile. In : B.P. SMITH (ed). Large Animal Internal Medicine, The C.V. Mosby Company, Missouri, USA, Muller-Berghaus, G., Ten Cate, H. and Levi, M., 999. Disseminated intravascular coagulation: clinical spectrum and established as well as new diagnostic approaches., Thrombosis and Haemostasis- F.K. Schattauer Verlagsgesellschhaft mbh (Stuttgart) 82 (2) Muylle, E., Hende, C.V.D., Sustronch, B. and Deprez, P., 990. Biochemical profiles in cows with abomasal displacement estimated by blood and liver parameters. J. Vet. Med. A. 37, Ogurtan, Z., Ok, M., İzci, C. and Ceylan, C., Activated partial thromboplastin time and prothrombin time in cows with left displacement abomasums. Indian Vet. J., 80 (3), Ritt, M.G., Rogers, K.S. and Thomas, J.S., 997. Nephrotic syndrome resulting in thromboembolic disease and diseminated intravascular coagulation in a dog. J. Am. Anim. Hosp. Assoc. 33, Turgut, K., Hemostazis: Koagülasyon ve Trombosit Bozuklukları. Veteriner Klinik Laboratuvar Teşhis. Bahçivanlar Basım. San. A. Ş. Konya., Turgut, K. and Ok, M., 997. Ruminatlarda abdominal ağrı olan veya olmayan anoreksi ve abdominal gerginlik ile karekterize hastalıklar. Veteriner Gastroenteroloji. Bahçivanlar Basım. San. A. Ş. Konya., Wallace, C.E., 989. Reticulo, omasal, abomasal volvulus in dairy cows. The Bovine Practitioner, 24, Yamahato, H., 982a. Clinical and pathological studies on the etiological factors of bovine abomasal displacement and atony. I. Clinical cases. Jpn. J. Vet. Sci., 44 (39), 5-6. Yamahato, H., 982b. Clinical and pathological studies on the etiological factors of bovine abomasal displacement and atony. II. Clinical cases. Jpn. J. Vet. Sci., 44 (54),
Disseminated intravascular coagulation (DIC) Dr. Klara Vezendi Szeged University Transfusiology Department
Disseminated intravascular coagulation (DIC) Dr. Klara Vezendi Szeged University Transfusiology Department Disseminated intravascular coagulation (DIC, consumptive coagulopathy) is a clinicopathologic
More informationEDUCATIONAL COMMENTARY DISSEMINATED INTRAVASCULAR COAGULATION
EDUCATIONAL COMMENTARY DISSEMINATED INTRAVASCULAR COAGULATION Educational commentary is provided through our affiliation with the American Society for Clinical Pathology (ASCP). To obtain FREE CME/CMLE
More informationApproach to disseminated intravascular coagulation
Approach to disseminated intravascular coagulation Khaire Ananta Shankarrao 1, Anil Burley 2, Deshmukh 3 1.MD Scholar, [kayachikitsa] 2.Professor,MD kayachikitsa. 3.Professor and HOD,Kayachikitsa. CSMSS
More informationACQUIRED COAGULATION ABNORMALITIES
ACQUIRED COAGULATION ABNORMALITIES ACQUIRED COAGULATION ABNORMALITIES - causes 1. Liver disease 2. Vitamin K deficiency 3. Increased consumption of the clotting factors (disseminated intravascular coagulation
More informationDIC. Bert Vandewiele Fellow Critical Care 23 May 2011
DIC Bert Vandewiele Fellow Critical Care 23 May 2011 Dissiminated Intravascular Coagulopathie 11/3/2011 Dr. Bert Vandewiele 2 Dissiminated Intravascular Coagulopathie = Consumption coagulopathie = Defibrination
More informationHEME 10 Bleeding Disorders
HEME 10 Bleeding Disorders When injury occurs, three mechanisms occur Blood vessels Primary hemostasis Secondary hemostasis Diseases of the blood vessels Platelet disorders Thrombocytopenia Functional
More informationDisseminated Intravascular Coagulation. M.Bahmanpour MD Assistant professor IUMS
به نام خدا Disseminated Intravascular Coagulation M.Bahmanpour MD Assistant professor IUMS Algorithm for Diagnosis of DIC DIC Score factor score Presence of known underlying disorder No= 0 yes=2 Coagolation
More informationL iter diagnostico di laboratorio nelle coagulopatie congenite emorragiche
L iter diagnostico di laboratorio nelle coagulopatie congenite emorragiche Armando Tripodi Angelo Bianchi Bonomi Hemophilia and Thrombosis Center Dept. of Clinical Sciences and Community Health University
More informationBLEEDING DISORDERS Simple complement:
BLEEDING DISORDERS Simple complement: 1. Select the statement that describe the thrombocytopenia definition: A. Marked decrease of the Von Willebrandt factor B. Absence of antihemophilic factor A C. Disorder
More informationDisseminated Intravascular Coagulation (DIC) Seminar. Ron Kopilov 4 th year Medical Student, Tel Aviv University Internal Medicine A 8.3.
Disseminated Intravascular Coagulation (DIC) Seminar Ron Kopilov 4 th year Medical Student, Tel Aviv University Internal Medicine A 8.3.2012 1 Our plan: Understand the pathophysiology Identify risk factors
More informationCoagulation Disorders. Dr. Muhammad Shamim Assistant Professor, BMU
Coagulation Disorders Dr. Muhammad Shamim Assistant Professor, BMU 1 Introduction Local Vs. General Hematoma & Joint bleed Coagulation Skin/Mucosal Petechiae & Purpura PLT wound / surgical bleeding Immediate
More informationHaemostasis & Coagulation disorders Objectives:
Haematology Lec. 1 د.ميسم مؤيد علوش Haemostasis & Coagulation disorders Objectives: - Define haemostasis and what are the major components involved in haemostasis? - How to assess the coagulation status?
More informationDISSEMINATED INTRAVASCULAR COAGULATION (DIC) Pichika Chantrathammachart MD Division of Hematology, Department of Medicine Ramathibodi Hospital
DISSEMINATED INTRAVASCULAR COAGULATION (DIC) Pichika Chantrathammachart MD Division of Hematology, Department of Medicine Ramathibodi Hospital Disseminated intravascular coagulation (DIC) Disseminated
More informationJohn Davidson Consultant in Intensive Care Medicine Freeman Hospital, Newcastle upon Tyne
John Davidson Consultant in Intensive Care Medicine Freeman Hospital, Newcastle upon Tyne Overview of coagulation Testing coagulation Coagulopathy in ICU Incidence Causes Evaluation Management Coagulation
More informationIndex. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A Acute lung injury (ALI) transfusion-related, 363 372. See also Transfusion-related acute lung injury (TRALI) ALI. See Acute lung injury
More informationProceedings of the World Small Animal Veterinary Association Sydney, Australia 2007
Proceedings of the World Small Animal Veterinary Association Sydney, Australia 2007 Hosted by: Australian Small Animal Veterinary Association (ASAVA) Australian Small Animal Veterinary Association (ASAVA)
More informationGeneral approach to the investigation of haemostasis. Jan Gert Nel Dept. of Haematology University of Pretoria 2013
General approach to the investigation of haemostasis Jan Gert Nel Dept. of Haematology University of Pretoria 2013 Clinical reasons to investigate haemostasis Investigating a clinically suspected bleeding
More informationThe Egyptian Journal of Hospital Medicine (July 2018) Vol. 72 (9), Page
The Egyptian Journal of Hospital Medicine (July 2018) Vol. 72 (9), Page 5210-5214 The Utility of Fibrinogen/C-reactive protein Ratio versus D-dimer and Fibrin Degradation Product in Diagnosis of Overt
More informationThe LaboratoryMatters
Laboratory Medicine Newsletter for clinicians, pathologists & clinical laboratory technologists. A Initiative. HEMOSTASIS AND THE LABORATORY This issue highlights: Primary Hemostasis Screening Tests Case
More informationApproach to bleeding disorders &treatment. by RAJESH.N General medicine post graduate
Approach to bleeding disorders &treatment by RAJESH.N General medicine post graduate 2 Approach to a patient of bleeding diathesis 1. Clinical evaluation: History, Clinical features 2. Laboratory approach:
More informationThis slide belongs to iron lecture and it is to clarify the iron cycle in the body and the effect of hypoxia on erythropoitein secretion
This slide belongs to iron lecture and it is to clarify the iron cycle in the body and the effect of hypoxia on erythropoitein secretion Topics of today lectures: Hemostasis Meaning of hemostasis Mechanisms
More informationPart IV Antithrombotics, Anticoagulants and Fibrinolytics
Part IV Antithrombotics, Anticoagulants and Fibrinolytics "The meaning of good and bad, of better and worse, is simply helping or hurting" Emerson Chapter 16: Blood Coagulation and Fibrinolytic System
More informationApproach To A Bleeding Patient
ABDUL MAJEED, RAHUL RAJEEV REVIEW ARTICLE INTRODUCTION Hemostasis is the process of forming clots in the walls of damaged blood vessels and preventing blood loss while maintaining blood in a fluid state
More informationMANAGEMENT OF COMMON BLEEDING DISORDERS. Auro Viswabandya Department of Haematology, CMC, Vellore
MANAGEMENT OF COMMON BLEEDING DISORDERS Auro Viswabandya Department of Haematology, CMC, Vellore BLOOD CLOT : PRIMARY HAEMOSTASIS (Platelets) + SECONDARY HAEMOSTASIS (Coagulation Factors) HAEMOSTATIC DISORDERS
More informationPrimary Exam Physiology lecture 5. Haemostasis
Primary Exam Physiology lecture 5 Haemostasis Haemostasis Body s response for the prevention and cessation of bleeding. Broadly consists of: Primary Haemostasis - vascular spasm and platlet plug formation
More informationFELINE HEMATOLOGY Inherited and Acquired Bleeding Disorders Marjory Brooks DVM, D.ACVIM
FELINE HEMATOLOGY Marjorie Brooks, D.V.M. Diplomate, A.C.V.I.M. Comparative Hematology Laboratory N.Y.S. Department of Health WCL&R P. O. Box 509 Albany, NY 12201 f / b - f / i 3 FELINE HEMATOLOGY Inherited
More informationRip roaring hematologic dysfunction from solid organ malignancies
Rip roaring hematologic dysfunction from solid organ malignancies A tale from UWMC hematology consult service in 4/2017 Lindsay Hannan, MD MSPH Discussant: Dr. Sioban Keel. Main objectives 1) DIC scoring
More informationA study of coagulation profile in neoplastic conditions
Research Article A study of coagulation profile in neoplastic conditions Sarmishtha M Patel, Swati Gupta, Mandakini M Patel, Juhi D Mahadik, Kinjal A Patel, Avani S Patel Department of Pathology, Government
More informationUNIT VI. Chapter 37: Platelets Hemostasis and Blood Coagulation Presented by Dr. Diksha Yadav. Copyright 2011 by Saunders, an imprint of Elsevier Inc.
UNIT VI Chapter 37: Platelets Hemostasis and Blood Coagulation Presented by Dr. Diksha Yadav Hemostasis: Prevention of Blood Loss Vascular constriction Formation of a platelet plug Formation of a blood
More informationCoagulation, Haemostasis and interpretation of Coagulation tests
Coagulation, Haemostasis and interpretation of Coagulation tests Learning Outcomes Indicate the normal ranges for routine clotting screen and explain what each measurement means Recognise how to detect
More informationChapter 19. Hemostasis
Chapter 19 Hemostasis Hemostasis Hemostasis is the cessation of bleeding stopping potentially fatal leaks important in small blood vessels not effective in hemorrhage excessive bleeding from large blood
More informationCoagulation an Overview Dr.Abdolreza Abdolr Afrasiabi Thal assem a & Heamophili hilia G ene i tic R esearc C en er Shiraz Medical Medic University
In The Name God Coagulation an Overview Dr.Abdolreza Afrasiabi Thalassemia & Heamophilia Genetic Research hcenter Shiraz Medical University Bleeding Clotting Hemostasis Review of platelet function Platelets
More informationBleeding Disorders: (Hemorrhagic Diatheses) Tests used to evaluate different aspects of hemostasis are the following:
Bleeding Disorders: (Hemorrhagic Diatheses) Excessive bleeding can result from: 1. Increased fragility of vessels. 2. Platelet deficiency or dysfunction. 3. Derangement of coagulation. 4. Combinations
More informationStudy of correlation of changes in D-DIMER levels and coagulation profile with the development of coagulation disorders
Original article: Study of correlation of changes in D-DIMER levels and coagulation profile with the development of coagulation disorders 1 Dr Gurpreet Singh, 2 Dr Mahima Sharma, 3 Dr R K Chrungoo, 4 Dr.
More informationManaging Coagulopathy in Intensive Care Setting
Managing Coagulopathy in Intensive Care Setting Dr Rock LEUNG Associate Consultant Division of Haematology, Department of Pathology & Clinical Biochemistry Queen Mary Hospital Normal Haemostasis Primary
More information*Corresponding author: Key words: neurotrauma, coagulopathy
COAGULOPATHY IN NEURO TRAUMA A PROSPECTIVE ANALYSIS OF THE INCIDENCE AND CAUSES OF COAGULOPATHY IN PATIENTS WITH PURE NEURO TRAUMA AND MIXED TRAUMA ADMITTED TO THE NATIONAL HOSPITAL SRI LANKA *Jayawickrama
More informationAortic Aneurysm-associated Disseminated Intravascular Coagulation that Responded Well to a Switch from Warfarin to Rivaroxaban
doi: 10.2169/internalmedicine.8666-16 http://internmed.jp CASE REPORT Aortic Aneurysm-associated Disseminated Intravascular Coagulation that Responded Well to a Switch from Warfarin to Rivaroxaban Yasuko
More informationcoagulation defect of paracetamol-induced hepatic necrosis
Gut, 1974, 15, 89-93 A controlled trial of heparin therapy in the coagulation defect of paracetamol-induced hepatic necrosis B. G. GAZZARD, R. CLARK, V. BORIRAKCHANYAVAT, AND ROGER WILLIAMS From the Liver
More informationLAMA SHATAT TTP, ITP, DIC
TTP, ITP, DIC Reduction in platelet number (thrombocytopenia) constitutes an important cause of generalized bleeding. A count less than 100,000 platelets/μl is generally considered to constitute thrombocytopenia.
More informationChristopher M. Lehman, MD, 1,3 Lori W. Wilson, MT(ASCP), MS, 3 and George M. Rodgers, MD, PhD 1-3. Abstract
Coagulation and Transfusion Medicine / D-DIMER FOR THE DIAGNOSIS OF DIC Analytic Validation and Clinical Evaluation of the STA LIATEST Immunoturbidimetric D-Dimer Assay for the Diagnosis of Disseminated
More informationDr. MUBARAK ABDELRAHMAN MD PEDIATRICS AND CHILD HEALTH Assistant Professor FACULTY OF MEDICINE -JAZAN
Dr. MUBARAK ABDELRAHMAN MD PEDIATRICS AND CHILD HEALTH Assistant Professor FACULTY OF MEDICINE -JAZAN The student should be able:» To identify the mechanism of homeostasis and the role of vessels, platelets
More informationGuidance for management of bleeding in patients taking the new oral anticoagulant drugs: rivaroxaban, dabigatran or apixaban
Guidance for management of bleeding in patients taking the new oral anticoagulant drugs: rivaroxaban, dabigatran or apixaban Purpose The aim of this guidance is to outline the management of patients presenting
More informationM B Garvey. University of Toronto
Do I really need that test??? M B Garvey Professor Emeritus University of Toronto St Michael s Hospital No relevant conflicts of interest 1 HEMOSTASIS IS LIKE LOVE Everybody talks about it, nobody understands
More informationChapter 3. Haemostatic abnormalities in patients with liver disease
Chapter 3 Haemostatic abnormalities in patients with liver disease Ton Lisman, Frank W.G. Leebeek 1, and Philip G. de Groot Thrombosis and Haemostasis Laboratory, Department of Haematology, University
More informationUpdate. Diagnostic. 1. Physiology. 2. Bleeding disorders
Diagnostic Update May 08 Notes on Disorders of Haemostasis Part 1 of 2 Part 2 will cover hypercoagulation and thrombosis and management of the common bleeding disorders. 1. Physiology Injury occurs to
More informationHemodynamic Disorders, Thrombosis, and Shock. Richard A. McPherson, M.D.
Hemodynamic Disorders, Thrombosis, and Shock Richard A. McPherson, M.D. Edema The accumulation of abnormal amounts of fluid in intercellular spaces of body cavities. Inflammation and release of mediators
More informationHeme (Bleeding and Coagulopathies) in the ICU
Heme (Bleeding and Coagulopathies) in the ICU General Topics To Discuss Transfusions DIC Thrombocytopenia Liver and renal disease related bleeding Lack of evidence in managing critical illness related
More informationBlood coagulation and fibrinolysis. Blood clotting (HAP unit 5 th )
Blood coagulation and fibrinolysis Blood clotting (HAP unit 5 th ) Vessel injury Antithrombogenic (Favors fluid blood) Thrombogenic (Favors clotting) 3 Major systems involved Vessel wall Endothelium ECM
More informationPakistan Veterinary Journal
RESEARCH ARTICLE Pakistan Veterinary Journal ISSN: 0253-8318 (PRINT), 2074-7764 (ONLINE) Accessible at: www.pvj.com.pk Evaluation of D-Dimer Concentrations in Clinically Ill Dogs with High Risk of Thromboembolic
More informationBlood clotting. Subsequent covalent cross-linking of fibrin by a transglutaminase (factor XIII) further stabilizes the thrombus.
Blood clotting It is the conversion, catalyzed by thrombin, of the soluble plasma protein fibrinogen (factor I) into polymeric fibrin, which is deposited as a fibrous network in the primary thrombus. Thrombin
More informationTopics of today lectures: Hemostasis
Topics of today lectures: Hemostasis Meaning of hemostasis Mechanisms of hemostasis - Vascular contraction - Platelets plug - Blood coagulation (clotting) - Structure and functions of platelets - Blood
More informationHemostasis Haemostasis means prevention of blood loss from blood vessels.
١ Hemostasis Haemostasis means prevention of blood loss from blood vessels. Bleeding is stopped by several mechanisms, which are: 1. Local vasoconstriction 2. Formation of platelet plug 3. Blood coagulation
More informationTest Name Results Units Bio. Ref. Interval
LL - LL-ROHINI (NATIONAL REFERENCE 135091667 Age 37 Years Gender Male 29/8/2017 120000AM 29/8/2017 100129AM 29/8/2017 113851AM Ref By Final COAGULATION ROFILE 1 ARTIAL THROMBOLASTIN TIME, ACTIVATED; ATT
More informationMANAGEMENT OF COAGULOPATHY AFTER TRAUMA OR MAJOR SURGERY
MANAGEMENT OF COAGULOPATHY AFTER TRAUMA OR MAJOR SURGERY 19th ANNUAL CONTROVERSIES AND PROBLEMS IN SURGERY Thabo Mothabeng General Surgery: 1 Military Hospital HH Stone et al. Ann Surg. May 1983; 197(5):
More informationHEMATOLOGY AND COAGULATION ANALYTIC PROTOCOLS
1 of 6 Policy #: 800 (PLH-800-13) Initiated Date: 12/4/2002 Reviewed Date: 8/1/2016 Subject: HEMATOLOGY AND COAGULATION ANALYTIC PROTOCOLS Approved by: Laboratory Director, Jerry Barker (electronic signature)
More informationCase Report Disseminated Intravascular Coagulopathy Caused by Uterine Leiomyoma with Sarcoma-Like Findings on Magnetic Resonance Imaging
Case Reports in Obstetrics and Gynecology, Article ID 978743, 4 pages http://dx.doi.org/10.1155/2014/978743 Case Report Disseminated Intravascular Coagulopathy Caused by Uterine Leiomyoma with Sarcoma-Like
More informationTest Name Results Units Bio. Ref. Interval
LL - LL-ROHINI (NATIONAL REFERENCE 135091668 Age 40 Years Gender Male 29/8/2017 120000AM 29/8/2017 100156AM 29/8/2017 120820M Ref By Final COAGULATION ROFILE 2 FACTOR VIII FUNCTIONAL /ACTIVITY (Electromechanical
More informationHemostasis and thrombosis in patients with liver disease. Ton Lisman, Dept Surgery, UMC Groningen, The Netherlands
Hemostasis and thrombosis in patients with liver disease Ton Lisman, Dept Surgery, UMC Groningen, The Netherlands Importance of the liver in hemostasis Synthesis of Coagulation factors Fibrinolytic proteins
More informationIntroduction to coagulation and laboratory tests
Introduction to coagulation and laboratory tests Marc Jacquemin Special Haemostasis Laboratory Center for Molecular and Vascular Biology University of Leuven Coagulation in a blood vessel: fibrin stabilises
More informationMassive transfusion: Recent advances, guidelines & strategies. Dr.A.Surekha Devi Head, Dept. of Transfusion Medicine Global Hospital Hyderabad
Massive transfusion: Recent advances, guidelines & strategies Dr.A.Surekha Devi Head, Dept. of Transfusion Medicine Global Hospital Hyderabad Massive Hemorrhage Introduction Hemorrhage is a major cause
More informationHemostasis Haemostasis means prevention of blood loss from blood vessels.
1 Hemostasis Haemostasis means prevention of blood loss from blood vessels. Bleeding is stopped by several mechanisms, which are: 1. Local vasoconstriction 2. Formation of platelet plug 3. Blood coagulation
More informationThursday, February 26, :00 am. Regulation of Coagulation/Disseminated Intravascular Coagulation HEMOSTASIS/THROMBOSIS III
REGULATION OF COAGULATION Introduction HEMOSTASIS/THROMBOSIS III Regulation of Coagulation/Disseminated Coagulation necessary for maintenance of vascular integrity Enough fibrinogen to clot all vessels
More informationPathophysiologie und Therapie bei Massenblutung
Swisstransfusion Bern, 7. September 2012 Pathophysiologie und Therapie bei Massenblutung Lorenzo ALBERIO Universitätsklinik für Hämatologie und Hämatologisches Zentrallabor Coagulopathy of Trauma Haemorrhage
More informationWhat are blood clots?
What are blood clots? Dr Matthew Fay GP Principal The Willows Medical Practice- Queensbury GPwSI and Co-Founder Westcliffe Cardiology Service GP Partner Westcliffe Medical Group Created 5/31/18 Dr. Matthew
More informationBlood products and plasma substitutes
Blood products and plasma substitutes Plasma substitutes Dextran 70 and polygeline are macromolecular substances which are metabolized slowly; they may be used to expand and maintain blood volume in shock
More informationProthrombin Complex Concentrate- Octaplex. Octaplex
Prothrombin Complex Concentrate- Concentrated Factors Prothrombin Complex Concentrate (PCC) 3- factor (factor II, IX, X) 4-factor (factors II, VII, IX, X) Activated 4-factor (factors II, VIIa, IX, X) Coagulation
More informationAgent Dose MoA/PK/Admin Adverse events Disadvantages Protamine Heparin: 1mg neutralizes ~ 100 units Heparin neutralization in ~ 5 min
Nanik (Nayri) Hatsakorzian Pharm.D/MPH candidate 2014 Touro University College of Pharmacy CA Bleeding Reversal Agents Agent Dose MoA/PK/Admin Adverse events Disadvantages Protamine Heparin: 1mg neutralizes
More informationCOAGULATIONS. Dr. Hasan Fahmawi, MRCP(UK), FRCP(Edin)
COAGULATIONS Dr. Hasan Fahmawi, MRCP(UK), FRCP(Edin) Haemostasis-blood must be maintained in a fluid state in order to function as a transport system, but must be able to solidify to form a clot following
More informationINHERITED COAGULOPATHY
Disorder Etiology Pathophysiology and Presentation Lab Findings and Diagnosis Treatment INHERITED COAGULOPATHY HEMOPHILIA A and B Hemophilia A: deficiency in XIII (85%) Hemophilia B: deficiency in IX (15%)
More informationStep 2. Common Blood Tests, and the Coulter Counter Readout
Step 2. Common Blood Tests, and the Coulter Counter Readout We will be learning about some common blood tests. We will not be preforming most of them in lab. The student should know their names, their
More informationCLINICAL FELLOWSHIP PROGRAM IN COAGULATION
CLINICAL FELLOWSHIP PROGRAM IN COAGULATION The Department of Pathology and Laboratory Medicine University of Alberta, Faculty of Medicine and Dentistry and Alberta Health Services CLINICAL FELLOWSHIP IN
More informationBleeding Disorders. Dr. Mazen Fawzi Done by Saja M. Al-Neaumy Noor A Mohammad Noor A Joseph Joseph
Bleeding Disorders Dr. Mazen Fawzi Done by Saja M. Al-Neaumy Noor A Mohammad Noor A Joseph Joseph Normal hemostasis The normal hemostatic response involves interactions among: The blood vessel wall (endothelium)
More informationInsights on the Quality of Coagulation Testing
Insights on the Quality of Coagulation Testing Piet Meijer ECAT Foundation The Netherlands No conflicts of interest HAEMOSTATIC BALANCE BLEEDING HAEMOSTATIC BALANCE THROMBOSIS HAEMOSTATIC BALANCE Thrombosis
More informationComparative study to assess coagulation abnormalities in breast cancer
RESEARCH A R T I C L E INTERNATIONAL JOURNAL Advancements in Life Sciences Date Received: 05/12/2013; Date Revised: 02/02/2014; Date Published Online: 02/25/2014 Open Access Comparative study to assess
More informationRecombinant Activated Factor VII: Useful. Department of Surgery Grand Rounds 11/8/10 David Mauchley MD
Recombinant Activated Factor VII: Useful Department of Surgery Grand Rounds 11/8/10 David Mauchley MD Hemostasis and Coagulation Traditional cascade model Two convergent pathways Series of proteolytic
More informationTitle. Author(s)Hayakawa, Mineji; Gando, Satoshi; Hoshino, Hirokatsu. CitationClinical and Applied Thrombosis/Hemostasis, 13(1): 6. Issue Date
Title A Prospective Comparative Study of Three Sets of Cri vs Japanese Criteria Author(s)Hayakawa, Mineji; Gando, Satoshi; Hoshino, Hirokatsu CitationClinical and Applied Thrombosis/Hemostasis, 13(1):
More informationHemostasis and. Blood Coagulation
Hemostasis and Blood Coagulation Events in Hemostasis The term hemostasis means prevention of blood loss. Whenever a vessel is severed or ruptured, hemostasis is achieved by several mechanisms: (1) vascular
More informationMassive Transfusion. MPQC Spring Summit April 29, Roger Belizaire MD PhD
Massive Transfusion MPQC Spring Summit April 29, 2015 Roger Belizaire MD PhD Take home points 1. Blood is always available. Requests for massive transfusion or emergency release typically only require
More informationHyperfibrinolysis and the risk of hemorrhage in stable cirrhotic patients
Asian Biomedicine Vol. 4 No. 2 April 2010; 199-206 Original article Hyperfibrinolysis and the risk of hemorrhage in stable cirrhotic patients Anoree Surawong a, Ponlapat Rojnuckarin a, Jumlong Juntiang
More informationAppendix 3 PCC Warfarin Reversal
Appendix 3 PCC Warfarin Reversal Reversal of Warfarin and Analogues 1. Principle of Procedure Guidelines for the Reversal of Oral-anticoagulation in the Event of Life Threatening Haemorrhage Prothrombin
More informationDiagnosis of hypercoagulability is by. Molecular markers
Agenda limitations of clinical laboratories to evaluate hypercoagulability and the underlying cause for thrombosis what is the INR the lupus anticoagulant and the antiphospholipid antibody syndrome hassouna
More informationMechanisms of Trauma Coagulopathy. Dr B M Schyma Changi General Hospital Singapore
Mechanisms of Trauma Coagulopathy Dr B M Schyma Changi General Hospital Singapore HAEMORRHAGE A continued cause of PREVENTABLE death. 24% of trauma patients are coagulopathic on arrival 1 56% of severe
More informationSysmex Educational Enhancement and Development No
SEED Coagulation Sysmex Educational Enhancement and Development No 2 2016 An approach to the bleeding patient The purpose of this newsletter is to provide an overview of the approach to the bleeding patient
More informationHemostasis. Learning objectives Dr. Mária Dux. Components: blood vessel wall thrombocytes (platelets) plasma proteins
Hemostasis Learning objectives 14-16 Dr. Mária Dux Components: blood vessel wall thrombocytes (platelets) plasma proteins Hemostatic balance! procoagulating activity anticoagulating activity 1 Thrombocytes
More informationSECTION XIX HEMATOLOGIC AND ONCOLOGIC DISEASE AND DYSFUNCTION CHAPTER 170 COAGULATION DISORDERS IN THE INTENSIVE CARE UNIT OVERVIEW OF COAGULATION
SECTION XIX HEMATOLOGIC AND ONCOLOGIC DISEASE AND DYSFUNCTION CHAPTER 170 COAGULATION DISORDERS IN THE INTENSIVE CARE UNIT ROBERT I. PARKER This chapter focuses on various pathophysiologic conditions associated
More informationBlood Thinner Agent. Done by: Meznah Al-mutairi Pharm.D Candidate PNU Collage of Pharmacy
Blood Thinner Agent Done by: Meznah Al-mutairi Pharm.D Candidate PNU Collage of Pharmacy Outline: Blood thinner agent definition. anticoagulants drugs. Thrombolytics. Blood thinner agent Therapeutic interference
More informationBleeding, Coagulopathy, and Thrombosis in the Injured Patient
Bleeding, Coagulopathy, and Thrombosis in the Injured Patient June 7, 2008 Kristan Staudenmayer, MD Trauma Fellow UCSF/SFGH Trauma deaths Sauaia A, et al. J Trauma. Feb 1995;38(2):185 Coagulopathy is Multi-factorial
More informationInstruments smart solutions & service IGZ Instruments AG Räffelstrasse 32 CH 8045 Zürich
ADP (Adenosine-5 -Diphosphate) 101312 3 x 0.5mL ADP is a lyophilized preparation of adenosine-5 -diphosphate. The working concentration of the reconstituted reagent is 2 x 10-4 M. ADP is for use in routine
More informationStudy design: Multicenter, randomized, controlled, cross-over, blinded PK comparison
Brand Name 1, 2 : Rixubis Generic Name 1, 2 : Coagulation factor IX recombinant Manufacturer 5 : Baxter Drug Class 1, 2, 3 : Antihemophilic agent Labeled Uses 1, 2 : Hemophilia B hemorrhage, routine prophylaxis,
More informationThe study has been approved by Ethics Commission. Informed consent has been given by all participants.
Evaluation of new 9NC Coagulation Tubes Background: Venous blood with sodium citrate is the most commonly obtained examination sample for coagulation determinations. The additive functions as an anticoagulant
More informationAnnex III. Summary of Product Characteristics and Package Leaflet
Annex III Summary of Product Characteristics and Package Leaflet 11 SUMMARY OF PRODUCT CHARACTERISTICS AND PACKAGE LEAFLET 12 SUMMARY OF PRODUCT CHARACTERISTICS 13 1. NAME OF THE MEDICINAL PRODUCT Tranexamic
More informationIntraoperative haemorrhage and haemostasis. Dr. med. Christian Quadri Capoclinica Anestesia, ORL
Intraoperative haemorrhage and haemostasis Dr. med. Christian Quadri Capoclinica Anestesia, ORL Haemostasis is like love. Everybody talks about it, nobody understands it. JH Levy 2000 Intraoperative Haemorrhage
More informationHemostatic derangement in Dengue infection
Hemostatic derangement in Dengue infection By Assoc. Prof. Darintr Sosothikul, MD Pediatric Hematology-Oncology division, King Chulalongkorn Memorial Hospital, Faculty of Medicine, Chulalongkorn University
More informationCirculatory Disturbances 5: Thrombosis, Embolism, Infarction, Shock
Circulatory Disturbances 5: Thrombosis, Embolism, Infarction, Shock Shannon Martinson, Feb 2016 http://people.upei.ca/smartinson/ VPM 152 General Pathology Thrombosis, Embolism, Infarction, Shock Learning
More informationHematology Review. CCRN exam. The Coagulation Cascade. The Coagulation Cascade. Components include: Intrinsic pathway Extrinsic pathway Common pathway
CCRN exam Hematology Review CCRN Review October 2013 Department of Critical Care Nursing Hematology is 2% of the exam Focus on coagulation cascade, DIC, and HIT Anatomy of the hematologic system Bone marrow
More informationManagement of Cirrhotic Patients Undergoing Non-Transplant Surgery
Management of Cirrhotic Patients Undergoing Non-Transplant Surgery Jason S. Wakakuwa, M.D. Assistant Professor of Anesthesia Director, Transplant Anesthesia Beth Israel Deaconess Medical Center I have
More informationPlatelet Disorders. By : Saja Al-Oran
Platelet Disorders By : Saja Al-Oran Introduction The platelet arise from the fragmentation of the cytoplasm of megakaryocyte in the bone marrow. circulate in the blood as disc-shaped anucleate particles
More informationBlood Lecture Test Questions Set 2 Summer 2012
Blood Lecture Test Questions Set 2 Summer 2012 1. Leukocytes are attracted to a site of injury or disease by: a. diapedesis b. chemotaxis c. leukocytosis d. heparin e. leukomotosis 2. Leukocytes leave
More informationPathology note 8 BLEEDING DISORDER
Pathology note 8 BLEEDING DISORDER Slide75 ( Types of clotting factors deficiency): Today we will talk about public public factor deficiency it could be acquired or inherited, acquired diseases are more
More informationEMSS17: Bleeding patients course material
EMSS17: Bleeding patients course material Introduction During the bleeding patients workshop at the Emergency Medicine Summer School 2017 (EMSS17) you will learn how to assess and treat bleeding patients
More information